215. ファロー四徴症 Tetralogy of Fallot Clinical trials / Disease details
臨床試験数 : 22 / 薬物数 : 48 - (DrugBank : 19) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 49
Showing 1 to 10 of 22 diseases
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04713657 (ClinicalTrials.gov) | March 30, 2022 | 13/1/2021 | Beta-blocker Administration for Cardiomyocyte Division | Mechanistic Clinical Trial of Beta-Blocker Administration For Reactivating Cardiomyocyte Division In Tetrology of Fallot Mechanistic Clinical Trial of Beta-Blocker Administration For Reactivating Cardiomyocyte Division In ... | Tetralogy of Fallot | Other: N-thymidine;Other: Urine Collection;Procedure: Echocardiogram;Procedure: Cardiac MRI;Drug: Propranolol Hydrochloride;Drug: Placebo;Procedure: Physical Exam;Other: Specimen Collection Other: N-thymidine;Other: Urine Collection;Procedure: Echocardiogram;Procedure: Cardiac MRI;Drug: Pr ... | Bernhard Kuhn | University of Pittsburgh | Not yet recruiting | N/A | 2 Months | All | 40 | Phase 1 | United States |
2 | NCT05186415 (ClinicalTrials.gov) | January 2022 | 20/12/2021 | Contrast Enhanced Three Dimensional Echocardiographic Quantification of Right Ventricular Volumes in Repaired Tetralogy of Fallot Contrast Enhanced Three Dimensional Echocardiographic Quantification of Right Ventricular Volumes in ... | Contrast Enhanced Three Dimensional Echocardiographic Quantification of Right Ventricular Volumes in Repaired Tetralogy of Fallot Contrast Enhanced Three Dimensional Echocardiographic Quantification of Right Ventricular Volumes in ... | Tetralogy of Fallot | Drug: Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON] | Nemours Children's Health System | Thomas Jefferson University | Not yet recruiting | 11 Years | N/A | All | 60 | Phase 1/Phase 2 | NULL |
3 | NCT05176782 (ClinicalTrials.gov) | December 15, 2021 | 15/12/2021 | Comparison Between Histidine-tryptophan-ketoglutarate Cardioplegia and Cold Blood Cardioplegia for Myocardial Protection for Fallot Tetralogy Patients Undergoing Total Repair Comparison Between Histidine-tryptophan-ketoglutarate Cardioplegia and Cold Blood Cardioplegia for M ... | Randomized Clinical Trial: Comparison Between Histidine-tryptophan-ketoglutarate Cardioplegia and Cold Blood Cardioplegia for Myocardial Protection for Fallot Tetralogy Patients Undergoing Total Repair Randomized Clinical Trial: Comparison Between Histidine-tryptophan-ketoglutarate Cardioplegia and Co ... | Anesthesia | Drug: HTK cardioplegia;Drug: Cold Cadioplegia | Ain Shams University | NULL | Recruiting | 6 Months | 5 Years | All | 52 | Early Phase 1 | Egypt |
4 | ChiCTR2000033234 | 2020-06-05 | 2020-05-25 | Comprehensive study for surgical effect and prognosis of Tetralogy of Fallot | A single-center ambispective cohort study for surgical effect and prognostic factors of Tetralogy of Fallot after surgical repair A single-center ambispective cohort study for surgical effect and prognostic factors of Tetralogy of ... | Tetralogy of Fallot | TOF AS:annlus-sparing repair;TOF TAPE:transannular patch enlargement; | Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and ... | NULL | Pending | Both | TOF AS:247;TOF TAPE:247; | N/A | China | ||
5 | NCT04017975 (ClinicalTrials.gov) | December 20, 2019 | 10/7/2019 | Optical Tissue Identification for Myocardial Architecture | Optical Tissue Identification for Myocardial Architecture (OPTIMA Study) | Ventricular Septal Defect;Complete Atrioventricular Canal;Tetralogy of Fallot With Pulmonary Stenosis Ventricular Septal Defect;Complete Atrioventricular Canal;Tetralogy of FallotWith Pulmonary Stenosis ... | Drug: Fluorescite;Device: Cellvizio 100 Series System with Confocal Miniprobes | Aditya Kaza | National Heart, Lung, and Blood Institute (NHLBI) | Recruiting | N/A | 18 Years | All | 70 | Phase 2 | United States |
6 | ChiCTR1900025513 | 2019-09-01 | 2019-08-31 | The safety and efficacy of preoperative oral supplementation of coenzyme Q10 in improving postoperative cardiac function in children with tetralogy of fallot (pulmonary atresia): a preliminary study The safety and efficacy of preoperative oral supplementation of coenzyme Q10 in improving postoperat ... | The safety and efficacy of preoperative oral supplementation of coenzyme Q10 in improving postoperative cardiac function in children with tetralogy of fallot (pulmonary atresia): a preliminary study The safety and efficacy of preoperative oral supplementation of coenzyme Q10 in improving postoperat ... | tetralogy of fallot (pulmonary atresia) | 01:N/A ;02:Oral coenzyme Q10, 2.5mg, t.i.d.;03:Oral coenzyme Q10, 5mg, t.i.d.;04:Oral coenzyme Q10, 10mg, t.i.d.;05:Oral coenzyme Q10, 20mg, t.i.d.; 01:N/A ;02:Oral coenzyme Q10, 2.5mg, t.i.d.;03:Oral coenzyme Q10, 5mg, t.i.d.;04:Oral coenzyme Q10, ... | Fuwai Central China Cardiovascualr Hospital | NULL | Pending | 0 | 2 | Both | 01:8;02:8;03:8;04:8;05:8; | China | |
7 | ChiCTR1800019578 | 2018-12-01 | 2018-11-18 | Effects of different tranexamic acid regimen in cyanotic pediatric cardiac surgery | Effects of different tranexamic acid regimen in cyanotic pediatric cardiac surgery | Tetralogy of Fallot | Conventional treatment group:Childen did not receive an antifibrinolytic agent during surgery;Low dose of tranexamic acid group:Loading dose: 10mg/kg (infant), 5mg/kg (children); Infusion: 2mg/kg.h; CPB prime dose: 20ug/mL of prime volume;High dose of tranexamic acid group:Loading dose: 30mg/kg (infant), 15mg/kg (children); Infusion: 6mg/kg.h; CPB prime dose: 60ug/mL of prime volume; Conventional treatment group:Childen did not receive an antifibrinolytic agent during surgery;Low do ... | National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and ... | NULL | Pending | Both | Conventional treatment group:225;Low dose of tranexamic acid group:225;High dose of tranexamic acid group:225; | China | |||
8 | NCT03835494 (ClinicalTrials.gov) | November 1, 2018 | 8/1/2019 | Analysis of RV-Dysfunction in Fallot Patients | Tissue Doppler Imaging - A Promising Technique To Assess Myocardial Function In Adult Fallot Patients Tissue Doppler Imaging - A Promising Technique To Assess Myocardial Function In Adult Fallot Patient ... | Tetralogy of Fallot | Other: Transthoracic echocardiography at rest, during PLR, HG and CPX (including blood gas analysis in both groups). Additionally Fallot patients will undergo routine blood testings. Other: Transthoracic echocardiography at rest, during PLR, HG and CPX (including blood gas analysis ... | Klinik für Kardiologie, Pneumologie und Angiologie | NULL | Completed | 18 Years | 80 Years | All | 60 | N/A | Germany |
9 | NCT03732742 (ClinicalTrials.gov) | November 2018 | 22/10/2018 | Comparison of Mid-term Results of Total Correction of TOF Between Preservation of PV and Trans-annular Patch. Comparison of Mid-term Results of Total Correction of TOF Between Preservation of PV and Trans-annul ... | Comparison of Mid-term Results of Total Correction of Tetralogy of Fallot Between Preservation of Pulmonary Valve and Trans-annular Patching Comparison of Mid-term Results of Total Correction of Tetralogy of FallotBetween Preservation of Pul ... | Tetrology of Fallot | Procedure: TOF repair with trans-annular patch VS preservation of PV | Assiut University | NULL | Unknown status | N/A | N/A | All | 50 | N/A | NULL |
10 | NCT03049995 (ClinicalTrials.gov) | November 2016 | 2/2/2017 | Stress Echo 2020 - The International Stress Echo Study | The International Stress Echo Study in Ischemic and Non-ischemic Heart Disease | Coronary Artery Disease;Heart Failure;Hypertrophic Cardiomyopathy;Aortic Valve Disease;Athletes Heart;Tetralogy of Fallot;Pulmonary Arterial Hypertension Coronary Artery Disease;Heart Failure;Hypertrophic Cardiomyopathy;Aortic Valve Disease;Athletes Hear ... | Procedure: Left ventricular contractile reserve SE;Procedure: B-lines SE;Procedure: Left ventricular outflow tract gradient SE;Procedure: Diastolic function SE;Procedure: Mitral regurgitation SE;Procedure: Pulmonary hemodynamics SE;Procedure: Coronary flow reserve SE Procedure: Left ventricular contractile reserve SE;Procedure: B-lines SE;Procedure: Left ventricular ... | Fatebenefratelli Hospital | Institute of Clinical Physiology, CNR, Pisa,Italy;Salerno Hospital, Italy;Monaldi Hospital, Napoli, Italy;University of Pisa, Italy;San Luca Hospital, Lucca, Italy;Careggi University Hospital, Florence, Italy;Federico II University;San Carlo Public Hospital, Potenza, Italy;Royal Brompton & Harefield NHS Foundation Trust;Ospedale dell'Angelo, Venezia-Mestre;University of Parma;Hospital Clinics, Trieste, Italy;Federal University of Rio Grande do Sul;Hospital San José, Criciuma, Brasil;Hospital San Vicente de Paulo, Passo Fundo, Brasil;University of Belgrade;University of Szeged, Hungary;Elisabeth Hospital, Hodmezovasarhely, Hungary;Sandro Pertini Hospital, Rome, Italy;Hospital Clinics, Bari, Italy;Ospedale Nottola, Siena, Italy;University of Catania, Italy;Medika Cardiocenter, Saint Petersburg, Russian Federation;Acibadem City Clinic Tokuda Hospital;Investigaciones Medicas, Buenos Aires, Argentina;Tomsk National Research Scientific Centre of Russian Academy of Sciences, Tomsk, Russian Federation;Instituto Nacional de Cardiología Mexico City, Mexico;Hamad Medical Corporation, Heart Hospital -Doha-Qatar Institute of Clinical Physiology, CNR, Pisa,Italy;Salerno Hospital, Italy;Monaldi Hospital, Napoli, ... | Recruiting | 18 Years | 85 Years | All | 300 | Italy |